XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Balance at period start (in shares) at Dec. 31, 2020   54,003,000      
Balance at period start at Dec. 31, 2020 $ 246,274 $ 540 $ 726,504 $ (477,028) $ (3,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock offering, net of issuance costs (in shares)   5,750,000      
Common stock offering, net of issuance costs 87,401 $ 58 87,343    
Stock-based compensation (in shares)   461,000      
Stock-based compensation 1,886 $ 3 1,883    
Purchase of common stock for retirement (in shares)   (76,000)      
Purchase of common stock for retirement (1,321)   (1,321)    
Exercise of stock options (in shares)   4,000      
Exercise of stock options 58   58    
Other comprehensive income 3,996       3,996
Net income (loss) (62,227)     (62,227)  
Balance at period end (in shares) at Mar. 31, 2021   60,142,000      
Balance at period end at Mar. 31, 2021 276,067 $ 601 814,467 (539,255) 254
Balance at period start (in shares) at Dec. 31, 2020   54,003,000      
Balance at period start at Dec. 31, 2020 246,274 $ 540 726,504 (477,028) (3,742)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (89,383)        
Balance at period end (in shares) at Sep. 30, 2021   60,193,000      
Balance at period end at Sep. 30, 2021 253,502 $ 602 819,057 (566,411) 254
Balance at period start (in shares) at Mar. 31, 2021   60,142,000      
Balance at period start at Mar. 31, 2021 276,067 $ 601 814,467 (539,255) 254
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock offering, net of issuance costs (208)   (208)    
Stock-based compensation (in shares)   1,000      
Stock-based compensation 2,079   2,079    
Purchase of common stock for retirement (2)   (2)    
Issuance of common stock for employee stock purchase plan (in shares)   42,000      
Issuance of common stock for employee stock purchase plan 714 $ 1 713    
Net income (loss) (108,958)     (108,958)  
Balance at period end (in shares) at Jun. 30, 2021   60,185,000      
Balance at period end at Jun. 30, 2021 169,692 $ 602 817,049 (648,213) 254
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation (in shares)   (5,000)      
Stock-based compensation 2,023   2,023    
Purchase of common stock for retirement (in shares)   13,000      
Purchase of common stock for retirement (15)   (15)    
Net income (loss) 81,802     81,802  
Balance at period end (in shares) at Sep. 30, 2021   60,193,000      
Balance at period end at Sep. 30, 2021 $ 253,502 $ 602 819,057 (566,411) 254
Balance at period start (in shares) at Dec. 31, 2021 60,161,955 60,162,000      
Balance at period start at Dec. 31, 2021 $ 265,700 $ 602 821,713 (559,117) 2,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation (in shares)   412,000      
Stock-based compensation 3,658 $ 3 3,655    
Purchase of common stock for retirement (in shares)   (462,000)      
Purchase of common stock for retirement (6,390) $ (4) (1,431) (4,955)  
Net income (loss) (137,051)     (137,051)  
Balance at period end (in shares) at Mar. 31, 2022   60,112,000      
Balance at period end at Mar. 31, 2022 $ 125,917 $ 601 823,937 (701,123) 2,502
Balance at period start (in shares) at Dec. 31, 2021 60,161,955 60,162,000      
Balance at period start at Dec. 31, 2021 $ 265,700 $ 602 821,713 (559,117) 2,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) $ 279,470        
Balance at period end (in shares) at Sep. 30, 2022 60,157,574 60,158,000      
Balance at period end at Sep. 30, 2022 $ 546,892 $ 601 829,195 (285,406) 2,502
Balance at period start (in shares) at Mar. 31, 2022   60,112,000      
Balance at period start at Mar. 31, 2022 125,917 $ 601 823,937 (701,123) 2,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation (in shares)   3,000      
Stock-based compensation 2,017   2,017    
Purchase of common stock for retirement (in shares)   (1,000)      
Purchase of common stock for retirement (94)   (94)    
Exercise of stock options (in shares)   65,000      
Exercise of stock options 1,132 $ 1 1,131    
Issuance of common stock for employee stock purchase plan (in shares)   41,000      
Issuance of common stock for employee stock purchase plan 632   632    
Net income (loss) 149,125     149,125  
Balance at period end (in shares) at Jun. 30, 2022   60,220,000      
Balance at period end at Jun. 30, 2022 278,729 $ 602 827,623 (551,998) 2,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation (in shares)   (2,000)      
Stock-based compensation 1,613   1,613    
Purchase of common stock for retirement (in shares)   (60,000)      
Purchase of common stock for retirement (846) $ (1) (41) (804)  
Net income (loss) $ 267,396     267,396  
Balance at period end (in shares) at Sep. 30, 2022 60,157,574 60,158,000      
Balance at period end at Sep. 30, 2022 $ 546,892 $ 601 $ 829,195 $ (285,406) $ 2,502